Fibroblasts are a highly heterogeneous cell population implicated in the pathogenesis of many human diseases. In human skin dermis, fibroblasts have traditionally been attributed to the superficial papillary or lower reticular dermis according to their histological localization. In mouse dermis, papillary and reticular fibroblasts originate from two different lineages with diverging functions regarding physiological and pathological processes and a distinct cell surface marker expression profile by which they can be distinguished.
Introduction
As the main cellular component of connective tissue, fibroblasts are primarily responsible for the deposition of collagen and elastic fibers that ultimately form the extracellular matrix 1 , and thus, their role in tissue homeostasis, regeneration and disease has been underestimated for a long time. However, fibroblasts have recently come under the spotlight of researchers, not only because they represent a prominent cellular source for induced pluripotent stem cells 2 but also because of their high plasticity and implication in the pathogenesis of a wide number of diseases such as organ fibrosis 3, 4, 5 or cancer 6, 7 .
Human skin is composed of a multi-layered epithelium, the epidermis, and its underlying connective tissue, the dermis, which can be histologically subdivided into the upper papillary and the lower reticular dermis and is mainly composed of fibroblasts and extracellular matrix 8 and the hypodermis. According to their location within the tissue, dermal fibroblasts have roughly been classified into papillary and reticular fibroblasts 1 .
Importantly, recent data indicate that these dermal fibroblast subpopulations are not only histologically distinguishable, but also that their function is considerably diverse. In mouse skin, papillary and reticular fibroblasts arise from two distinct lineages during embryogenesis 9 . Several lines of evidence suggest that the two lineages exert different roles not only in tissue homeostasis, hair follicle morphogenesis, wound repair and fibrosis 7, 9, 10 , but they also respond to different signals from neoplastic epidermal stem cells 11 , suggesting diverging roles in cancer pathogenesis. Conveniently, both lineages express a distinct set of mutually exclusive cellular markers in adult mouse skin, thus enabling the isolation of pure dermal fibroblast populations and subsequent extensive analysis of their specific functions in vitro 9, 11 . Correspondingly, at least two distinct fibroblast subsets with distinct morphology and functions, including diverging proliferation rates, tissue remodeling capacities 12, 13 , as well as the ability to support the growth of epidermal stem cells in vitro, have been described for human skin dermis + fibroblasts belong to the reticular lineage of the lower dermal compartments, which are less proliferative but readily undergo adipogenesis-a hallmark for reticular fibroblasts. This method enables to extensively study these distinct fibroblast subpopulations not only in regard to their specific functions under physiological conditions but also in the context of the pathogenesis of cutaneous diseases including skin cancer.
However, since fibroblasts alter their cell surface marker expression in two-dimensional in vitro culture 16, 17, 19 , the application of our protocol is limited to the isolation of primary fibroblasts from human dermis and does not permit the identification of papillary or reticular fibroblasts in mixed cell culture populations. Importantly, although the expression of cell surface markers changes in vitro, we have demonstrated that the fibroblast subsets isolated according to the protocol described below retain their specific functionality when cultivated 16 , thus enabling in vitro studies of subset-specific properties under physiological or pathological conditions.
In conclusion, we developed a protocol for the isolation of distinct fibroblast subsets via FACS that for the first time permits the isolation of pure fibroblast populations from human skin dermis in a naïve state.
Protocol
Human skin was obtained from Caucasian men and women aged 26 to 61 years (sun-protected skin; abdominal corrections, breast reductions). Written informed patient consent was obtained before tissue collection in accordance with the Declaration of Helsinki, and with approval from the Vienna Medical University Institutional Review Board.
NOTE:
We provide a protocol for the isolation of functionally distinct fibroblast subpopulations either from full thickness dermis (please refer to section 1) or after sectioning human skin dermis into its different layers (skip section 1 and directly refer to section 2).
Preparation of Full Thickness Dermis
1. Place a 10 cm x 10 cm human skin piece (e.g., from abdominal corrections or breast reductions) with the epidermis facing downwards on thick filter paper. 2. Hold the epidermis tightly on its edges with forceps and scrape off the subcutaneous fat layer with a scalpel. Then slice the tissue into 5 mm wide strips before putting them into a Petri dish. NOTE: This facilitates penetration of Dispase II (referred to as dissociating enzyme henceforth, see section 3) and is used if the epidermis needs to be separated from the entire dermis. For this skip section 2 and directly refer to section 3. To avoid contamination, keep the tissue sterile after surgical removal or clean it thoroughly with ethanol or iodine solution. If at all, ethanol treatment of the skin surface causes only minor cell death. Work under sterile conditions in a tissue culture flow hood.
Sectioning of Human Skin Dermis into Papillary and Reticular Layers with a Dermatome
1. Place a 10 cm x 10 cm skin piece (e.g., from abdominal corrections or breast reductions) on thick filter paper, with the epidermis facing upwards. Hold the skin tightly on its edges with forceps. 2. Slice the skin with an electric dermatome, adjusted to a cutting thickness/depth of 300 µm, by sliding the head of the dermatome away from oneself, with the blade being at a 90° angle in relation to the surface of the skin. 3. Take the first layer consisting of epidermis and papillary dermis (300 µm thick, "Dermal layer 1", Figure 1 and Figure 2 ) and put it in a Petri dish. Proceed immediately to section 3 or add 1x PBS to keep the tissue from drying out. NOTE: To avoid contamination, keep tissue sterile after surgical removal or clean it thoroughly with ethanol or iodine solution. Work under sterile conditions in a tissue culture flow hood. CAUTION: Handle dermatome carefully since the blades are very sharp. 4. Repeat step 2.2 adjusting the dermatome to a cutting thickness of 700 µm and slice the remaining dermis. Place the upper slice which is defined as the upper reticular dermis ("Dermal layer 2", Figure 2 ) into a separate Petri dish. Proceed immediately to section 4 or add 1x PBS to keep the tissue from drying out. 5. Scrape away the subcutaneous fat layer with a scalpel from the residual lower reticular dermal layer (>1,000 µm) and discard it. Collect the lower reticular dermis ("Dermal layer 3", Figure 2 ) in another Petri dish. Proceed immediately to section 4 or add 1x PBS to keep the tissue from drying out. NOTE: Alternatively, instead of scraping the fat off with a scalpel, remove the fat layer with scissors. It may help to put the reticular dermis on ice prior to scraping the fat away.
Enzymatic Digestion of Dermal Tissue
1. Mince each dermal layer (Dermal layer 1, 2 and 3) separately with scissors/scalpel as thoroughly as possible; the smaller the pieces, the better the tissue digestion.
NOTE:
The toughness of the dermis can vary depending on the body part it originates from (e.g., abdominal or upper arm skin). 2. Prepare the digestion mix by combining 1.25 mg/mL collagenase I, 0.5 mg/mL collagenase II, 0.5 mg/mL collagenase IV and 0.1 mg/mL hyaluronidase in Dulbecco's modified Eagle's medium (DMEM) with L-glutamine (see Table of Materials), 10% fetal calf serum (FCS) and 1% penicillin/streptomycin (P/S). CAUTION: Work carefully with collagenases as these may irritate skin and eyes upon contact. 3. Put each of the minced tissues with 10 mL of the prepared digestion mix into a 50 mL tube and incubate in a 37 °C warm water bath for 1 h under permanent agitation. During digestion invert the tubes several times. NOTE: One should consider adjusting the digestion volume according to the size of the minced skin piece. Do not overload 10 mL digestion mix with too much tissue otherwise the cell yield will be minimal. Less than one third of tissue within the total volume is recommended (1:2 w/ v).
Preparation of Single Cell Suspension and Erythrocyte Lysis
1. Stop enzymatic tissue digestion by adding 10 mL fibroblast medium (DMEM with L-glutamine, 10% FCS and 1% P/S) to the digested tissue. Work on ice from here on. 2. Pour the contents of each tube through a regular sterile stainless tea strainer and collect cell suspension in a clean Petri dish. Wash the strainer with medium and mash undigested tissue pieces with the edge of a syringe-plunger. 3. Afterwards, pipette collected cell suspension through a 70 µm cell strainer into a 50 mL tube. Rinse the cell strainer with medium and collect flow through into the same tube. 4. Centrifuge tubes at 500 x g at 4 °C for 10 min. Remove and discard supernatant and wash cell pellet with 5 mL fibroblast medium. Repeat the centrifugation step. 5. Remove and discard the supernatant and resuspend the pellet in 1 mL self-made ACK erythrocyte lysis buffer (0.15 M NH 4 Cl, 10 mM KHCO 3 , 0.1 mM Na 2 EDTA; pH 7.2-7.4). Leave cells in lysis buffer for approximately 1 min at ambient temperature (20-22 °C). 6. Stop lysis by adding 9 mL of 1x PBS with 10% FCS and centrifuge the tubes again at 500 x g at 4 °C for 5 min. Discard the supernatant.
CAUTION: The incubation time in erythrocyte lysis may be adjusted if the lysis seems incomplete (red pellet). However, do not leave the cells in erythrocyte lysis buffer for too long to avoid lysis of fibroblasts and immune cells. 
Blocking and Staining Fibroblasts for FACS

Culturing of Fibroblasts and Adipogenesis Assay
1. Following FACS, spin cells down at 500 x g for 3 min at 4 °C and plate equal cell numbers (5,000-10,000 cells/well) in fibroblast growth medium (see the Table of Materials) in 48-well cell culture dishes. Leave cells to grow until they reach 70% confluency. 2. Add 5 µg/mL insulin, 5 µM troglitazone, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX) and 1 µM dexametasone to fibroblast growth medium to prepare adipocyte differentiation medium. 
Discussion
In this article, we describe a method for the isolation of papillary and reticular fibroblasts from human skin. CD90 has been widely used for the identification or isolation of dermal fibroblasts 18, 20, 21 . However, we have demonstrated that besides CD90+ fibroblasts, human dermis also harbors a CD90 -fibroblast population expressing FAP 16 , which has been established as a marker for activated fibroblasts and cancer-associated fibroblasts (CAFs) 22, 23, 24, 25 . Importantly, we were able to identify three fibroblast subpopulations FAP biopsies from all healthy human donors. We therefore conclude that FAP is not only a marker for activated fibroblasts or CAFs but also normal tissue fibroblasts.
Of note, the FAP -CD90 -cell population remaining after application of the above-described exclusion-and gating strategy does not contain fibroblasts, since these cells do not proliferate in fibroblast cultivation medium in vitro, but most likely a mixed cell population including lymphatic cells and pericytes amongst others 16 .
The cell yield obtained by use of the above-described protocol can vary depending on the body-part that the skin piece used for the isolation originates from. Dermis from different body parts differs regarding its structure, thickness as well as collagen composition. For example, skin from the face or the upper arm is much thinner than skin from the belly or the thigh, which also frequently display a thicker subcutaneous fat layer. Additionally, age and sex of the skin donors may further not only impact the tissue dissociation efficiency, but may also affect the distribution of the three fibroblast subpopulations (Figure 3 ) when isolated from full thickness skin. This results from the fact that the papillary dermis shrinks and that total fibroblast numbers decrease with age 11, 26, 27, 28 . Furthermore, the cell pellet from papillary dermis will probably be larger than from reticular dermis, since the upper dermis is more densely populated by fibroblasts than the reticular dermis. Besides, the lower dermis is also tougher and more densely packed with collagen, making it harder to dissociate the tissue and to release the fibroblasts. Of note, the cell pellet may appear very red, which is why red blood cell lysis is recommended.
In addition to the identification of three subpopulations in intact human skin, we also show that in dermatomed skin, each fibroblast subset is enriched either in papillary or reticular dermis 16 . Precise slicing of the skin with the dermatome is critical to obtain a proper enrichment of each subpopulation from different dermal layers. Since the papillary dermis is very thin, the dermatomed slice representing it should not exceed a thickness of 300 µm. Upper reticular and lower reticular fibroblasts both represent the reticular lineage and display similar functions and gene signatures, therefore, one could also consider not separating them.
Importantly, all three fibroblasts populations are found throughout the dermis and are not exclusively present in one layer, which is why explant cultures from papillary or reticular dermis result in mixed fibroblast cultures. However, FAP . Furthermore, the majority of CD90 + fibroblasts of the papillary dermis are almost exclusively found surrounding blood vessels and express the perivascular fibroblast marker CD146 29 , and thus probably exhibit different functions than the remaining CD146 -reticular fibroblasts 16 . CD146 could be used as an additional marker in the gating strategy to exclude this population.
Following the dissociation of dermal layers, the isolated cells are stained with a specially designed antibody cocktail containing various antibodies for the exclusion of immune cells, endothelial and lymphatic cells, epidermal cells, erythrocytes and MSCs to obtain pure fibroblast populations. Of note, choosing a marker for the identification and exclusion of MSCs may be tricky because of the high number of published MSC markers 30, 31 . . We therefore emphasize that the above-described marker sets and protocol permit the isolation of primary fibroblast subsets directly from the tissue but not from previously cultured mixed fibroblast populations.
Nevertheless, we demonstrate that the functionality of all three subpopulations is retained in cell culture regardless of the alteration of cell surface marker expression, since fibroblasts sorted as FAP +
CD90
-papillary fibroblasts do not acquire the ability to undergo adipogenesis after a longer period of culture, while fibroblasts sorted as FAP + CD90 + or FAP -CD90 + reticular fibroblasts maintain their ability to differentiate into adipocytes 16 . Importantly, we also found that papillary and reticular-specific genes are still expressed to a higher extent in FAP + CD90 -and CD90 + respectively.
In conclusion, we have established a protocol for the isolation of functionally distinct fibroblast subsets via FACS that for the first time permits the isolation and analysis of pure and naïve fibroblast subpopulations from human skin dermis. This method establishes a major advancement to the commonly used fibroblast explant culture isolation protocol from upper and lower dermis as (i) an opposing gradient of papillary and reticular fibroblasts exists from the skin surface to the hypodermis and (ii) fibroblasts change their gene signature in vitro.
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